Background & Aims: The CCNE1 locus, which encodes cyclin E1, is amplified in many types of cancer cells and is activated in hepatocellular carcinomas (HCCs) from patients infected with hepatitis B virus or adeno-associated virus type 2, due to integration of the virus nearby. We investigated cell cycle and oncogenic effects of cyclin E1 overexpression in tissues of mice. Methods:We generated mice with doxycycline-inducible expression of Ccnel (Ccne1 T mice) and activated overexpression of cyclin E1 from age 3 weeks onwards. At 14 months of age, livers were collected from mice that overexpress cyclin E1 and non-transgenic mice (controls) and analyzed

Cyclin A2 activates the cyclin-dependent kinases Cdk1 and Cdk2 and is expressed at elevated levels from S phase until early mitosis. We found that mutant mice that cannot elevate cyclin A2 are chromosomally unstable and tumor-prone. Underlying the chromosomal instability is a failure to up-regulate the meiotic recombination 11 (Mre11) nuclease in S phase, which leads to impaired resolution of stalled replication forks, insufficient repair of double-stranded DNA breaks, and improper segregation of sister chromosomes. Unexpectedly, cyclin A2 controlled Mre11 abundance through a C-terminal RNA binding domain that selectively and directly binds Mre11 transcripts to mediate polysome loading and translation.These data reveal cyclin A2 as a mechanistically diverse regulator of DNA replication combining multifaceted kinase-dependent functions with a kinase-independent, RNA binding–dependent role that ensures adequate repair of common replication errors.

No abstract

BubR1 is a key component of the spindle assembly checkpoint (SAC). Mutations that reduce BubR1 abundance cause aneuploidization and tumorigenesis in humans and mice, whereas BubR1 overexpression protects against these. However, how supranormal BubR1 expression exerts these beneficial physiological impacts is poorly understood. Here, we used Bub1b mutant transgenic mice to explore the role of the amino-terminal (BubR1N) and internal (BubR1I) Cdc20-binding domains of BubR1 in preventing aneuploidy and safeguarding against cancer. BubR1N was necessary, but not sufficient to protect against aneuploidy and cancer. In contrast, BubR1 lacking the internal Cdc20-binding domain provided protection against both, which coincided with improved microtubule-kinetochore attachment error correction and SAC activity. Maximal SAC reinforcement occurred when both the Phe- and D-box of BubR1I were disrupted. Thus, while under- or overexpression of most mitotic regulators impairs chromosome segregation fidelity, certain manipulations of BubR1 can positively impact this process and therefore be therapeutically exploited.DOI: http://dx.doi.org/10.7554/eLife.16620.001

PQÿ STUVW XW ÿ VY Xÿ ZQ[W XY\X]ÿ ^Q_ XZ`_ VY ÿ W ab c ZPXW ÿ c PVc ÿ VZc ÿ VW ÿ W b dePVc ÿ ZVc V_ klXÿ c PXÿ STUe hQ`[]ÿ W c Vc Xm ÿ STUVW Xÿ VZc b \Vc b [dÿ fY Qc Xb [W ÿ s SwUW v ÿ c PVc ÿ W c b ^`_ Vc Xÿ STUÿ Pk]Y Q_ kW b W ÿ V[]ÿ d`V[b [Xÿ ]b W W QZb Vc b Q[ÿ b [Pb hb c QY W ÿ c PVc ÿ hb []ÿ rPQÿ STUVW XW ÿ b [ÿ c PXÿ SxUe hQ`[]ÿ W c Vc Xÿ c Qÿ fY X\X[c ÿ hQc Pÿ STUÿ XgZPV[dXÿ V[]ÿ Y X_ QZVc b Q[ÿ c Qÿ W `hZX_ _ `_ VY ÿ _ QZVc b Q[W ÿ aPXY Xÿ rPQÿ STUVW XW ÿ VY Xÿ VZc b \X n q ÿ UQW c e c Y V[W _ Vc b Q[V_ ÿ ^Q]b j b ZVc b Q[W ÿ ZQ[c Y b h`c Xÿ c Qÿ c PXÿ W fVc b Qe c X^fQY V_ ÿ ZQ[c Y Q_ ÿ Qj ÿ rPQÿ STUVW XW m ÿ b [Z_ `]b [dÿ fY X[k_ Vc b Q[m ÿ fPQW fPQYk_ Vc b Q[ÿ V[]ÿ `hb y`b c b [Vc b Q[ z q ÿ UXY c `Y hVc b Q[W ÿ b [ÿ c PXÿ b [c Y b ZVc Xÿ W b d[V_ b [dÿ [Xc aQY iW ÿ c PVc ÿ _ XV]ÿ c Qÿ Q\XY VZc b \Vc b Q[ÿ Qj ÿ rPQÿ STUVW XW ÿ PV\Xÿ hXX[ÿ_ b [iX]ÿc Qÿ[XQf_ VW c b ZÿZX_ _ ÿdY Qac P {onn q ÿUVY c b Z`_ VY _ kÿQ\XY VZc b \Ve c b Q[ÿ Qj ÿ StuW ÿ VffXVY W ÿ c Qÿ hXÿ Vÿ fY Q^b [X[c ÿ W Q`Y ZXÿ Qj ÿ `[ZQ[c Y Q_ _ X]ÿ rPQÿ STUVW Xÿ VZc b \b c kÿ b [ÿ P`^V[ÿ ^V_ b d[V[Zb XW n| q }[Xÿ Qj ÿ c PXW Xÿ StuW m ÿ tZc |m ÿ VZc b \Vc XW ÿ rPQwm ÿ rVZnÿ V[]ÿ ~]Zp|m ÿ V[]ÿ VW ÿ W `ZPÿ f_ VkW ÿ Vÿ ZX

BubR1 is a key component of the spindle assembly checkpoint (SAC). Mutations that reduce BubR1 abundance cause aneuploidization and tumorigenesis in humans and mice, whereas BubR1 overexpression protects against these. However, how supranormal BubR1 expression exerts these beneficial physiological impacts is poorly understood. Here, we used Bub1b mutant transgenic mice to explore the role of the amino-terminal (BubR1 N ) and internal (BubR1 I ) Cdc20-binding domains of BubR1 in preventing aneuploidy and safeguarding against cancer. BubR1 N was necessary, but not sufficient to protect against aneuploidy and cancer. In contrast, BubR1 lacking the internal Cdc20-binding domain provided protection against both, which coincided with improved microtubule-kinetochore attachment error correction and SAC activity. Maximal SAC reinforcement occurred when both the Phe-and D-box of BubR1 I were disrupted. Thus, while under-or overexpression of most mitotic regulators impairs chromosome segregation fidelity, certain manipulations of BubR1 can positively impact this process and therefore be therapeutically exploited.

No abstract